Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBREXAFUNGERP vs IBUPROFEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBREXAFUNGERP vs IBUPROFEN: Safety Overview

Metric IBREXAFUNGERP IBUPROFEN
Total FAERS Reports 129 87,008
Deaths Reported 6 6,705
Death Rate 4.7% 7.7%
Hospitalizations 9 29,386
Average Patient Age 44.4 yrs 44.0 yrs
% Female Patients 85.2% 60.9%
FDA Approval Date Jun 1, 2021 Approved Prior to Jan 1, 1982
Manufacturer N/A Wal-Mart Stores Inc
Route N/A ORAL
Marketing Status Prescription Discontinued